Double Competitors

002901 Stock

32.74 0.69 2.15%

Double Medical Technology competes with Dazhong Transportation, Lander Sports, Kingsignal Technology, Jiugui Liquor, and Northking Information; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Double Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Double Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Double Medical Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Double Medical competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
30.79	33.85	36.91

Details

Intrinsic

Valuation

Low	Real	High
24.82	27.88	36.01

Details

Earnings

Estimates (0)

Low	Projected EPS	High
0.00	0.00	0.00

Details

Double Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Double Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Double and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Double Medical Technology does not affect the price movement of the other competitor.

	900903	000558	300252	000799	002987	002627	002177	002990
900903		0.92	0.94	0.94	0.89	0.89	0.93	0.9	900903
000558	0.92		0.94	0.9	0.84	0.92	0.95	0.89	000558
300252	0.94	0.94		0.97	0.94	0.93	0.96	0.96	300252
000799	0.94	0.9	0.97		0.91	0.93	0.96	0.96	000799
002987	0.89	0.84	0.94	0.91		0.85	0.86	0.93	002987
002627	0.89	0.92	0.93	0.93	0.85		0.94	0.94	002627
002177	0.93	0.95	0.96	0.96	0.86	0.94		0.93	002177
002990	0.9	0.89	0.96	0.96	0.93	0.94	0.93		002990
	900903	000558	300252	000799	002987	002627	002177	002990

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Double Stock performing well and Double Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Double Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
900903	2.52	0.48	0.08	1.43	2.43	(5.15)	5.56	(5.00)	14.79
000558	2.42	0.39	0.08	(3.33)	2.86	(2.88)	6.08	(4.24)	18.29
300252	3.08	0.57	0.08	(0.76)	4.06	(3.31)	6.33	(5.35)	34.46
000799	2.94	0.57	0.17	2.13	2.60	(3.70)	10.00	(4.14)	19.06
002987	3.23	0.79	0.16	(1.95)	3.34	(3.50)	9.99	(6.24)	18.64
002627	1.32	0.22	0.03	(0.48)	1.80	(1.60)	3.32	(1.78)	17.12
002177	3.14	0.51	0.10	1.69	4.03	(3.20)	8.64	(6.63)	20.03
002990	2.55	0.41	0.09	(5.40)	2.77	(2.86)	7.23	(4.64)	19.99

Cross Equities Net Income Analysis

Compare Double Medical Technology and related stocks such as Dazhong Transportation, Lander Sports Development, and Kingsignal Technology Net Income Over Time

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
900903	512 M	512 M	512 M	512 M	512 M	512 M	558.9 M	872.6 M	881.6 M	981.2 M	535.4 M	328.4 M	(272.8 M)	324.2 M	419.7 M
000558	13.3 M	61.6 M	62.9 M	67.5 M	43 M	(358.4 M)	25.2 M	28.5 M	(61.1 M)	26 M	(71.7 M)	(94.2 M)	(36.2 M)	56.2 M	59 M
300252	35.3 M	33.1 M	32.2 M	23.2 M	83.4 M	138.5 M	195.4 M	130.1 M	131.6 M	71.4 M	(66 M)	46.6 M	(377.8 M)	(326.5 M)	(310.2 M)
000799	86.2 M	192.6 M	495.4 M	88.6 M	88.6 M	88.6 M	108.6 M	176.1 M	222.7 M	299.5 M	491.6 M	893.5 M	1 B	547.8 M	307.2 M
002987	46.3 M	46.3 M	46.3 M	46.3 M	46.3 M	46.3 M	46.3 M	48.4 M	78 M	174.7 M	276.1 M	230.6 M	277 M	347.6 M	203.3 M
002627	36.9 M	104.2 M	78.3 M	60.2 M	63.3 M	47.8 M	50.9 M	110.8 M	95 M	115.1 M	48.3 M	105.3 M	4.3 M	129.6 M	83.9 M
002177	34.8 M	178.8 M	124.1 M	124.4 M	132 M	69.4 M	23.2 M	13.8 M	(94.8 M)	67.3 M	71.8 M	(61.8 M)	54.2 M	15.4 M	14.7 M
002990	46.9 M	46.9 M	46.9 M	46.9 M	46.9 M	46.9 M	46.9 M	71.4 M	141.8 M	213.1 M	224.4 M	179.2 M	96.4 M	198.2 M	161.1 M

Double Medical Technology and related stocks such as Dazhong Transportation, Lander Sports Development, and Kingsignal Technology Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Double Medical Technology financial statement analysis. It represents the amount of money remaining after all of Double Medical Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Double Medical Competitive Analysis

The better you understand Double Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Double Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Double Medical's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	002901	900903	000558	300252	000799	002987	002627	002177	002990
	2.15 32.74 Double	3.70 0.26 Dazhong	1.03 2.94 Lander	0.33 8.99 Kingsignal	1.58 56.65 Jiugui	0.48 14.41 Northking	1.95 5.24 Hubeiyichang	1.67 4.72 Guangzhou	0.61 23.25 Maxvision
Market Volatility (90 Days Market Risk)	Not too volatile	Out of control	Very risky	Moderately volatile	Very steady	Somewhat reliable	Slightly risky	Relatively risky	Not too volatile
Market Performance (90 Days Performance)	Solid	Good	Good	Good	Solid	Good	OK	Good	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Low	Below Average	Low	Low	Low	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Strong Sell	Cautious Hold	Strong Sell	Strong Sell	Strong Sell	Strong Sell
Net Asset	4.64 B	18.48 B	2 B	5.17 B	5.67 B	3.07 B	4.25 B	1.73 B	3.55 B
Profit Margin	0.1	0.0762	0.32	-0.16	0.0669	0.0712	0.16	0.77	0.1
EBITDA	282.18 M	826.19 M	40.64 M	(151.29 M)	138.24 M	309.93 M	203.18 M	16.08 M	129.54 M
Operating Margin	0.24	0.16	-0.85	-0.0059	-0.4	0.0996	0.29	0.03	0.0788
Current Valuation	12.66 B	2.34 B	4.13 B	6.59 B	17.07 B	8.63 B	2.8 B	3.19 B	4.99 B
Price To Book	4.29	0.46	3.51	2.76	4.59	3.3	1.23	2.11	2.55
Retained Earnings	1.28 B	6.08 B	(206.04 M)	(104.3 M)	2.56 B	1.18 B	686.8 M	811.2 M	915.33 M
Beta	0.14	0.15	0.4	-0.024	1.33	0.11	0.54	1.04	1.16
Number Of Employees	4.03 K	4.78 K	283	3.22 K	2.03 K	30.63 K	2.1 K	199	1.18 K
Shares Outstanding	414.02 M	800.81 M	1.29 B	662.15 M	324.93 M	619.26 M	724.6 M	761.19 M	256.03 M
Cash Flow From Operations	73.86 M	171.42 M	72.93 M	(26.63 M)	51.24 M	131.03 M	378.82 M	25 M	103.36 M
Annual Yield	0.0076	N/A	N/A	N/A	0.0177	0.0105	0.0192	0.003	0.0172
Total Debt	316.13 M	2.12 B	448.88 M	1.44 B	1.39 B	526.76 M	380.68 M	33.41 M	1.25 B
Return On Equity	0.0717	0.0315	0.048	-0.16	0.0306	0.13	0.04	0.0377	0.0602
Return On Asset	0.0243	0.0096	-0.0062	-0.0356	0.0095	0.0601	0.0125	3.0E-4	0.0209
Book Value Per Share	7.76	4.08	0.84	3.14	12.34	4.38	4.43	2.23	9.14
Total Asset	4.64 B	18.48 B	2 B	5.17 B	5.67 B	3.07 B	4.25 B	1.73 B	3.55 B
Target Price	41.0	7.27	N/A	N/A	48.38	19.98	N/A	18.14	N/A
Last Dividend Paid	0.25	0.05	N/A	N/A	1.0	0.12	0.1	0.01	0.4
Shares Owned By Institutions	3.45	3.99	1.12	1.7	8.06	1.9	3.24	1.3	0.76
Market Capitalization	13.54 B	2.01 B	3.8 B	6.08 B	18.49 B	9.98 B	3.8 B	3.55 B	5.83 B
Price To Earnings To Growth	N/A	N/A	N/A	N/A	2.03	N/A	N/A	N/A	N/A
Price To Sales	6.99	0.57	21.59	3.07	9.84	1.93	4.37	43.83	4.35
Net Income	58.97 M	324.16 M	56.19 M	(326.52 M)	547.81 M	347.63 M	129.64 M	15.45 M	198.23 M
Earnings Per Share	0.48	0.02	0.04	-0.5	0.39	0.53	0.19	0.02	0.54
Shares Owned By Insiders	86.31	19.87	43.49	37.83	32.16	62.89	52.58	20.4	72.08
Revenue	1.53 B	4.5 B	255.18 M	2 B	2.83 B	4.24 B	1.6 B	70.06 M	1.57 B
Working Capital	2 B	3.47 B	16.79 M	199.47 M	2.91 B	2.12 B	1.59 B	483.78 M	1.76 B
Gross Profit	1.68 B	832.74 M	34.47 M	444.28 M	3.2 B	827.68 M	103.91 M	47.97 M	382.32 M
Day Typical Price	32.69	0.26	2.94	8.94	56.9	14.38	5.22	4.71	23.17
Accumulation Distribution	0.0393	0.0385	0.0432	0.0417	0.0503	0.0409	0.0321	0.0598	0.0344
Market Facilitation Index	1.31	0.01	0.13	0.38	2.94	0.6	0.17	0.29	0.81
Daily Balance Of Power	0.5267	(1.00)	0.2308	(0.08)	0.2993	(0.12)	0.5882	(0.28)	0.1728
Period Momentum Indicator	0.69	(0.01)	0.03	(0.03)	0.88	(0.07)	0.1	(0.08)	0.14
Rate Of Daily Change	1.02	0.96	1.01	1.0	1.02	1.0	1.02	0.98	1.01
Day Median Price	32.67	0.26	2.95	8.92	57.03	14.36	5.22	4.71	23.14
Price Action Indicator	0.42	N/A	0.01	0.055	0.06	0.015	0.075	(0.03)	0.19
Coefficient Of Variation	535.52	653.71	873.83	927.58	658.35	569.79	1083.85	744.34	827.24
Mean Deviation	2.05	2.52	2.42	3.08	2.94	3.23	1.32	3.14	2.55
Jensen Alpha	0.5785	0.483	0.3938	0.57	0.5673	0.7885	0.2231	0.5137	0.4094
Total Risk Alpha	0.0813	(0.02)	(0.15)	(0.23)	(0.02)	0.0771	(0.14)	(0.1)	(0.13)
Sortino Ratio	0.1826	0.0778	0.0806	0.0849	0.1673	0.161	0.0284	0.0962	0.093
Downside Variance	5.1	27.5	10.52	19.45	8.3	15.06	4.5	20.35	9.19
Standard Deviation	2.9	3.51	3.41	4.67	4.02	4.29	2.05	4.19	3.4
Kurtosis	2.64	0.4947	1.93	5.47	0.9856	0.3153	8.09	0.5792	1.5
Potential Upside	5.36	5.56	6.08	6.33	10.0	9.99	3.32	8.64	7.23
Treynor Ratio	(1.32)	1.43	(3.33)	(0.76)	2.13	(1.95)	(0.48)	1.69	(5.40)
Maximum Drawdown	17.3	14.79	18.29	34.46	19.06	18.64	17.12	20.03	19.99
Variance	8.39	12.31	11.63	21.77	16.17	18.43	4.19	17.52	11.54
Market Risk Adjusted Performance	(1.31)	1.44	(3.32)	(0.75)	2.14	(1.94)	(0.47)	1.7	(5.39)
Risk Adjusted Performance	0.1501	0.1247	0.0952	0.0908	0.1242	0.1424	0.0768	0.1109	0.1001
Skewness	0.8817	0.0182	0.3591	0.5524	0.8791	0.3984	(0.12)	(0.15)	0.2971
Semi Deviation	1.86	2.43	2.86	4.06	2.6	3.34	1.8	4.03	2.77
Information Ratio	0.1423	0.1163	0.0767	0.0802	0.1199	0.1455	0.0294	0.1036	0.083
Value At Risk	(3.24)	(5.00)	(4.24)	(5.35)	(4.14)	(6.24)	(1.78)	(6.63)	(4.64)
Expected Short fall	(2.56)	(5.15)	(2.88)	(3.31)	(3.70)	(3.50)	(1.60)	(3.20)	(2.86)
Downside Deviation	2.26	5.24	3.24	4.41	2.88	3.88	2.12	4.51	3.03
Semi Variance	3.46	5.89	8.21	16.51	6.78	11.13	3.25	16.27	7.69

Double Medical Competition Performance Charts

Five steps to successful analysis of Double Medical Competition

Double Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Double Medical Technology in relation to its competition. Double Medical's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Double Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Double Medical's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Double Medical Technology, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Double Medical position

In addition to having Double Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Medical Equipment Thematic Idea Now

Medical Equipment

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Medical Equipment theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Medical Equipment Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Double Stock

Double Medical financial ratios help investors to determine whether Double Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Double with respect to the benefits of owning Double Medical security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Double Competitors

Specify up to 10 symbols:

Double Medical Competition Correlation Matrix

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Double Medical Technology and related stocks such as Dazhong Transportation, Lander Sports Development, and Kingsignal Technology Net Income description

Double Medical Competitive Analysis

Double Medical Competition Performance Charts

Five steps to successful analysis of Double Medical Competition

Complement your Double Medical position

Did You Try This Idea?

Run Medical Equipment Thematic Idea Now

Medical Equipment

Other Information on Investing in Double Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY